First Chemical Evaluation and Toxicity of Casinga-cheirosa to Balb-c Male Mice
Carregando...
Citações na Scopus
19
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI AG
Autores
ESTORK, Dirce M.
GUSMAO, Daniela F.
PACIENCIA, Mateus L. B.
DIAZ, Ingrit E. C.
VARELLA, Antonio D.
YOUNES, Riad N.
REIS, Luiz F. L.
BERNARDI, Maria M.
SUFFREDINI, Ivana B.
Citação
MOLECULES, v.19, n.4, p.3973-3987, 2014
Resumo
Laetia suaveolens, known as ""casinga-cheirosa"", crude extract EB719 has previously shown cytotoxic activity against prostate cancer and squamous cell carcinoma. For the first time, seven molecules were isolated from its apolar-alpha-tocopherol (1) and sitosterol (2)-and polar-3-O-caffeoylquinic acid (3), 4-O-caffeoylquinic acid (4), 5-O-feruloylquinic acid (5), hyperoside (6), and isoquercitrin (7)-fractions. Acute toxicity was determined in a two-stage experiment: (1) a reduced number of Balb-c male mice received 5000 mg/kg of EB719 to allow evaluation of general activity and other 27 parameters, plus death, up to the establishment of non-lethal dose (NLD), as well as lethal dose 50% (LD50); (2) NLD was administered and diazepam introduced as reference drug. EB719 showed LD50 = 178.0 mg/kg, and NLD 156.3 mg/kg. In stage one EB719 did not influence general activity, but provoked impairment in grasp reflexes, tail squeeze and breathing; piloerection and cyanosis were increased. In stage two, alterations occurred in auricular reflex, piloerection and breathing after diazepam administration, but not in response to EB719. Intestinal hemorrhage caused by local bleeding was observed after necropsy, and may be the main cause of animals' death other than a systemic effect of the extract. Although the isolated compounds are biologically and pharmacologically active in both men and animal systems, it is premature to relate their occurrence in EB719 to the observed intestine hemorrhage in mice.
Palavras-chave
Laetia suaveolens, Salicaceae, toxicity, alpha-tocopherol, isoquercitrin
Referências
- Arriaga Alba Myriam, 2008, BMC Pharmacology, V8, P2, DOI 10.1186/1471-2210-8-2
- Awad AB, 2005, PROSTAG LEUKOTR ESS, V72, P219, DOI 10.1016/j.plefa.2004.11.005
- Barros S.B.M., 2008, FUNDAMENTOS TOXICOLO, P59
- Beutler JA, 2000, PHYTOCHEMISTRY, V55, P233, DOI 10.1016/S0031-9422(00)00281-8
- Bouic PJD, 1996, INT J IMMUNOPHARMACO, V18, P693, DOI 10.1016/S0192-0561(97)85551-8
- Brito A.S., 1994, MANUAL ENSAIOS TOXIC, P122
- Gama J. R. V., 2007, Revista Árvore, V31, P465, DOI 10.1590/S0100-67622007000300012
- Gusmao D. F., 2013, PHARMACOLOGYONLINE, V1, P113
- Hasani Parisa, 2007, Acta Pharmaceutica (Zagreb), V57, P123, DOI 10.2478/v10007-007-0010-z
- Henry GE, 2006, CANCER LETT, V244, P190, DOI 10.1016/j.canlet.2005.12.022
- HOLLAND HL, 1978, CAN J CHEM, V56, P3121, DOI 10.1139/v78-510
- Huilgol N G, 2005, J Cancer Res Ther, V1, P38
- Jullian V, 2005, BIOORG MED CHEM LETT, V15, P5065, DOI 10.1016/j.bmcl.2005.07.090
- Khan M. R., 1999, Fitoterapia, V70, P96, DOI 10.1016/S0367-326X(99)00005-2
- Masuda Y, 1999, EXP ANIM TOKYO, V48, P209, DOI 10.1538/expanim.48.209
- MATSUO M, 1976, TETRAHEDRON, V32, P229, DOI 10.1016/0040-4020(76)87006-8
- Miller LG, 1998, ARCH INTERN MED, V158, P2200, DOI 10.1001/archinte.158.20.2200
- Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s
- Nugroho A, 2013, J PHARMACEUT BIOMED, V76, P139, DOI 10.1016/j.jpba.2012.12.021
- Ozi JM, 2011, BRAZ ORAL RES, V25, P519, DOI 10.1590/S1806-83242011000600008
- Reno F, 2005, BIOMATERIALS, V26, P5594, DOI 10.1016/j.biomaterials.2005.02.015
- Revilla R, 2002, PLANTAS UTEIS BACIA, V1, P371
- Romagnolo Donato F., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P206, DOI 10.1080/21551197.2012.702534
- Srivastava V, 2005, BIOORGAN MED CHEM, V13, P5892, DOI 10.1016/j.bmc.2005.05.066
- STICH HF, 1991, MUTAT RES, V259, P307, DOI 10.1016/0165-1218(91)90125-6
- Strauch MA, 2013, J ETHNOPHARMACOL, V145, P50, DOI 10.1016/j.jep.2012.10.033
- Suffredini IB, 2007, FITOTERAPIA, V78, P223, DOI 10.1016/j.fitote.2006.11.011
- Suffredini IB, 2006, PHARMAZIE, V61, P722
- Suffredini Ivana Barbosa, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P367
- Suffredini IB, 2007, PHARMAZIE, V62, P798, DOI 10.1691/ph.2007.10.6767
- Sundarraj S, 2012, J ETHNOPHARMACOL, V141, P803, DOI 10.1016/j.jep.2012.03.014
- TAKAHASHI O, 1990, TOXICOLOGY, V63, P157
- Vale LHF, 2011, CURR TOP MED CHEM, V11, P2566